We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

121 hedge funds and large institutions have $1.29B invested in Lexicon Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more call options, than puts

Call options by funds: $4.86M | Put options by funds: $2.62M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

37% more capital invested

Capital invested by funds: $940M → $1.29B (+$351M)

22% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 37

1.11% less ownership

Funds ownership: 103.95% → 102.84% (-1.1%)

4% less funds holding

Funds holding: 126 → 121 (-5)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

Holders
121
Holders Change
-5
Holders Change %
-3.97%
% of All Funds
2.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
11
Increased
45
Reduced
37
Closed
15
Calls
$4.86M
Puts
$2.62M
Net Calls
+$2.25M
Net Calls Change
+$3.14M

Top Buyers

1
AG
Artal Group
Luxembourg
+$20.1M
2
Millennium Management
Millennium Management
New York
+$4.39M
3
BlackRock
BlackRock
New York
+$2M
4
PCM
Price Capital Management
Louisiana
+$1.38M
5
CLM
ClearBridge LLC (Maryland)
Maryland
+$1.31M

Top Sellers

1
UIM
USS Investment Management
United Kingdom
-$22.6M
2
State Street
State Street
Massachusetts
-$6.86M
3
TCM
Tekla Capital Management
Massachusetts
-$1.98M
4
PA
Pinnacle Associates
New York
-$1.19M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
51
Virtus ETF Advisers
New York
$680K -$340K -33,209 -37%
ProShare Advisors
52
ProShare Advisors
Maryland
$602K -$42.5K -4,160 -8%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$590K – – –
ARTA
54
A.R.T. Advisors
New York
$513K -$117K -11,466 -21%
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$499K +$13.8K +1,354 +3%
Northwestern Mutual Wealth Management
56
Northwestern Mutual Wealth Management
Wisconsin
$484K -$23.6K -2,306 -5%
FRM
57
Fox Run Management
Connecticut
$459K -$71.6K -6,998 -15%
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$430K -$3.81K -373 -1%
UOTTAIMCU
59
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$429K – – –
Two Sigma Advisers
60
Two Sigma Advisers
New York
$407K +$197K +19,229 +131%
Susquehanna International Group
61
Susquehanna International Group
Pennsylvania
$406K +$140K +13,668 +68%
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
$403K +$1.5K +147 +0.4%
LPL Financial
63
LPL Financial
California
$399K +$41.7K +4,073 +14%
VRS
64
Virginia Retirement Systems
Virginia
$376K -$378K -37,000 -54%
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$349K +$6.34K +620 +2%
Invesco
66
Invesco
Georgia
$345K +$153K +14,916 +108%
CSS
67
Cubist Systematic Strategies
Connecticut
$341K +$24.3K +2,373 +9%
AIG
68
American International Group
New York
$338K +$6.19K +605 +2%
Commonwealth Equity Services
69
Commonwealth Equity Services
Massachusetts
$328K +$26.6K +2,600 +11%
Wells Fargo
70
Wells Fargo
California
$301K -$213K -20,823 -45%
MIM
71
MetLife Investment Management
New Jersey
$286K – – –
QSS
72
Quantitative Systematic Strategies
Florida
$262K +$27.1K +2,650 +14%
CIM
73
CIM Investment Management
Pennsylvania
$236K -$236K -23,025 -54%
TI
74
Trexquant Investment
Connecticut
$236K -$10.3K -1,007 -5%
GF
75
Gabelli Funds
New York
$228K +$14.3K +1,400 +8%
1 2
3
4 5

LXRX Hedge Fund Activity: Q2 2018 in Review

121 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q2 2018, worth a combined $1.29B — up 37% from $940M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of LXRX and 11 opened new positions — a net loss of 4 holders — while 37 trimmed existing stakes and 45 added.

The largest buyer was Artal Group, adding an estimated $20.1M. The largest seller was USS Investment Management, exiting entirely with an estimated $22.6M sold.

  • 121 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q2 2018, down from 126 in Q1 2018.
  • Funds reported $1.29B of Lexicon Pharmaceuticals stock for Q2 2018, up 37% quarter-over-quarter.
  • 11 funds opened new Lexicon Pharmaceuticals positions in Q2 2018 and 15 closed out, a net change of -4 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q2 2018 was Artal Group, an estimated $20.1M added.
  • The largest Lexicon Pharmaceuticals seller in Q2 2018 was USS Investment Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q2 2018.